4.5 Editorial Material

A brave NEO world: Neoadjuvant osimertinib in resectable EGFR-mutant NSCLC

Journal

LUNG CANCER
Volume 181, Issue -, Pages -

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.lungcan.2023.107256

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available